DHT and IGF-1 in peripheral blood lymphocytes: New markers for the biological passport of athletes

Journal of Biological Regulators and Homeostatic Agents

Volumn 27, Issue 3, 2013, Pages 757-770

  Mancini, A ^a,b   Imperlini, E ^b   Alfieri, A ^a,c   Spaziani, S ^a,d   Martone, D ^d   Parisi, A ^e   Orru S ^a,b   Buono, P ^a,b  

^a UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^b IRCCS SDN   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^e UNIVERSITY OF ROME FORO ITALICO   (Italy)

Author keywords

Biomarkers; Doping; Gene signature; Microarray

Indexed keywords

ANDROSTANOLONE; CCL1 CHEMOKINE; CXCL13 CHEMOKINE; FIBRONECTIN; FIBRONECTIN 1; GRANZYME 2 CYTOTOXIC T LYMPHOCYTE ASSOCIATED SERINE ESTERASE 1; INDOLEAMINE 2,3 DIOXYGENASE; INDOLEAMINE 2,3 DIOXYGENASE 1; INTERLEUKIN 2 RECEPTOR ALPHA; RAB PROTEIN; RAB31 PROTEIN; SERINE PROTEINASE; SOMATOMEDIN C; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; BIOLOGICAL MARKER; TRANSCRIPTOME;

ADULT; ARTICLE; ATHLETE; BIOINFORMATICS; CONTROLLED STUDY; DOPING; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; PERIPHERAL LYMPHOCYTE; PILOT STUDY; UPREGULATION; YOUNG ADULT; BLOOD; CHEMISTRY; LYMPHOCYTE;

ADULT; ATHLETES; BIOLOGICAL MARKERS; DIHYDROTESTOSTERONE; DOPING IN SPORTS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LYMPHOCYTES; MALE; TRANSCRIPTOME;

EID: 84891617885     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Fitch KD. Androgenic-anabolic steroids and the Olympic Games. Asian J Androl 2008; 10:384-90.
2. Wada report of adverse analytical finding (2009). http://www.wada-ama. org/Documents/Science-Medicine/Anti-Doping-Laboratories/Lab-Statistics/ Wada-2009-LaboratoryStatisticsReport-Final.pdf (accessed August 2010).
3. Shackleton CH, Roitman E, Phillips A, Chang T. Androstanediol and 5-androstenediol profiling for detecting exogenously administered dihydrotestosterone, epitestosterone, and dehydroepiandrosterone: potential use in gas chromatography isotope ratio mass spectrometry. Steroids 1997; 62:665-73.
4. Donike M, Ueki M, Kuroda Y, et al. Detection of dihydrotestosterone (DHT) doping: alterations in the steroid profile and reference ranges for DHT and its 5 alpha-metabolites. J Sports Med Phys Fitness 1995; 35:235-50.
5. Keller A, Wu Z, Kratzsch J, et al. Pharmacokinetics and pharmacodynamics of GH: dependence on route and dosage of administration. Eur J Endocrinol 2007; 156:647-53.
6. Kirsch S, Widart J, Louette J, et al. Development of an absolute quantification method targeting growth hormone biomarkers using liquid chromatography coupled to isotope dilution mass spectrometry. J Chromatogr 2007; 1153:300-6.
7. Abellan R, Ventura R, Pichini S, et al., Effect of Physical fitness and endurance exercise on indirect biomarkers of recombinant growth hormone misuse: insulin-like growth factor and procollagen Type III peptide. Int J Sports Med 2007; 28: 9-15.
8. Sartorio A, Agosti F, Marazzi N, et al. Combined evaluation of resting IGF-1, Nterminal propeptide of type III procollagen (PIIINP) and C-terminal crosslinked telopeptide of type I collagen (ICTP) levels might be useful for detecting inappropriate GH administration in athletes: a preliminary report. Clin Endocrinol 2004; 61:487-93.
9. Sottas PE, Saugy M, Saudan C. Endogenous steroid profiling in the athlete biological passport. Endocrinol Metab Clin North Am 2010; 39:59-73.
10. Imperiini E, Mancini A, Spaziani S, et al. Androgen receptor signaling induced by supraphysiological doses of dihydrotestosterone in human peripheral blood lymphocytes. Proteomics 2010; 10:3165-75.
11. WADA. Athlete Biological Passport operating guidelines and compilation of required elements-January 2012-Version 3.0:1-52.
12. Liss B. Improved quantitative real-time RT-PCR for expression profiling of individual cells. Nucleic Acids Res 2002; 30:e89.
13. Munn DH, Mellor AL. Indoleamine 2,3 dioxygenase and metabolic control of immune responses. Trends Immunol 2013; 34:137-43.
14. Loetscher P, Moser B. Homing chemokines in rheumatoid arthritis. Arthritis Res 2002;4:233e6.
15. White GE, Iqbal AJ, Greaves DR. CC chemokine receptors and chronic inflammation-therapeutic opportunities and pharmacological challenges. Pharmacol Rev 2013; 65:47-89.
16. Boivin WA, Shackleford M, Vanden Hoek A, Zhao H, Hackett TL, Knight DA, Granville DJ. Granzyme B cleaves decorin, biglycan and soluble betaglycan, releasing active transforming growth factor-β1. PLoS One 2012; 7:e33163.
17. Kocabaş A, Karagüzel G, Imir N, Yavuzer U, Akçurin S. Effects of vitamin D receptor gene polymorphisms on susceptibility to disease and bone mineral density in Turkish patients with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2010; 23:1289-97.
18. Smolders J, Thewissen M, Theunissen R, et al. Vitamin D-related gene expression profiles in immune cells of patients with relapsing remitting multiple sclerosis. J Neuroimmunol 2011; 235:91-7.
19. Fritzsching B, Haas J, König F, et al. Intracerebral human regulatory T cells: analysis of CD4+ CD25+ FOXP3+ T cells in brain lesions and cerebrospinal fluid of multiple sclerosis patients. PLoS One 2011; 6:e17988.
20. Watkins SK, Zhu Z, Riboldi E, et al. FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer. J Clin Invest 2011; 121:1361-72.
21. Takeyama H, Kyoda S, Okamoto T, et al. The expression of sialic fibronectin correlates with lymph node metastasis of thyroid malignant neoplasmas. Anticancer Res 2011; 31:1395-8.
22. Newell AE, Fiedler SE, Ruan JM, Pan J, Wang PJ, Deininger J, Corless CL, Carr DW. Protein kinase A RII-like (R2D2) proteins exhibit differential localization and AKAP interaction. Cell Motil Cytoskeleton 2008; 65:539-52.
23. Bao X, Faris AE, Jang EK, Haslam RJ. Molecular cloning, bacterial expression and properties of Rab31 and Rab32. Eur J Biochem 2002; 269:259-71.
24. Lipnik K, Naschberger E, Gonin-Laurent N, et al. Interferon gamma-induced human guanylate binding protein 1 inhibits mammary tumor growth in mice. Mol Med 2010; 16:177-87.
25. Minella D, Biancolella M, Testa B, Prosperini G, Zenobi R, Novelli G, Giganti MG. Androgen- and insulin-related gene signature using a specific low density oligoarray AndroChip 2 in peripheral blood mononuclear cells in agonists, recreational athletes and sedentary subjects. J Biol Regul Homeost Agents 2010; 24:413-23.
26. Bonizzi G, Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004; 25:280-8.
27. Chen CD, Sawyers CL. NF-kappa B activates prostate-specific antigen expression and is upregulated in androgen-independent prostate cancer. Mol Cell Biol 2002; 22:2862-70.
28. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev 2004; 18:2195-224.
29. Pärssinen M, Kujala U, Vartiainen E, Sarna S, Seppälä T. Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. Int J Sports Med 2000; 21:225-7.